| Literature DB >> 26120138 |
Karambir Kaur1, Himani Tandon1, Amit Kumar Gupta1, Manoj Kumar2.
Abstract
CRISPR system is a powerful defense mechanism in bacteria and archaea to provide immunity against viruses. Recently, this process found a new application in intended targeting of the genomes. CRISPR-mediated genome editing is performed by two main components namely single guide RNA and Cas9 protein. Despite the enormous data generated in this area, there is a dearth of high throughput resource. Therefore, we have developed CrisprGE, a central hub of CRISPR/Cas-based genome editing. Presently, this database holds a total of 4680 entries of 223 unique genes from 32 model and other organisms. It encompasses information about the organism, gene, target gene sequences, genetic modification, modifications length, genome editing efficiency, cell line, assay, etc. This depository is developed using the open source LAMP (Linux Apache MYSQL PHP) server. User-friendly browsing, searching facility is integrated for easy data retrieval. It also includes useful tools like BLAST CrisprGE, BLAST NTdb and CRISPR Mapper. Considering potential utilities of CRISPR in the vast area of biology and therapeutics, we foresee this platform as an assistance to accelerate research in the burgeoning field of genome engineering.Entities:
Mesh:
Year: 2015 PMID: 26120138 PMCID: PMC4483309 DOI: 10.1093/database/bav055
Source DB: PubMed Journal: Database (Oxford) ISSN: 1758-0463 Impact factor: 3.451
Figure 1.General mechanism of CRISPR/Cas genome editing.
Figure 2.CrisprGE design.
Figure 3.CrisprGE statistics: graphs are representing the statistical distribution of the (A) organism (B) cell lines (C) assay. PCR, polymerase chain reaction; T7E1, T7 endonuclease1 assay; HMA, heteroduplex mobility assay; HRMA, high-resolution melting assay; RFLP, restriction fragment length polymorphism; RE, restriction enzyme assay; CAPS, Cleaved Amplified Polymorphic Sequences; SSA assay, Single-strand annealing assay.
Figure 4.Bar graph is signifying length of insertions and deletion of various genes. Del, deletion; Ins, insertion and p, point mutation.
List of top genes targeted by CRISPR/Cas system
| Number of entries | Organism | |
|---|---|---|
| 252 | Mus musculus, Rattus norvegicus, Xenopus tropicalis, Danio rerio | |
| 238 | Arabidopsis thaliana, Nicotiana benthamiana | |
| 155 | Nicotiana tabacum, Nicotiana benthamiana, Oryza sativa, citrus sinensis | |
| 125 | Rattus norvegicus, Mus musculus | |
| 118 | Rattus norvegicus, Mus musculus | |
| 108 | Arabidopsis thaliana | |
| 95 | Rattus norvegicus, Mus musculus | |
| 92 | Oryza sativa | |
| 88 | Rattus norvegicus, Mus musculus | |
| 87 | Glycine max | |
| 86 | Homo sapiens | |
| 81 | Mus musculus | |
| 80 | Homo sapiens | |
| 72 | Danio rerio | |
| 72 | Homo sapiens | |
| 70 | Homo sapiens | |
| 69 | Rattus norvegicus, Danio rerio | |
| 68 | Rattus norvegicus, Mus musculus | |
| 67 | Rattus norvegicus, Mus musculus | |
| 66 | Arabidopsis thaliana, Nicotiana benthamiana |
DMD, duchenne muscular dystrophy.
Comparison of genome editing efficiency with different methods
| Organism/species | Gene | Method | Modification method | Efficiency (%) | Efficiency detection method | PMID |
|---|---|---|---|---|---|---|
| CCR5 | CRISPR/Cas9 | NHEJ | 76 | T7E1 assay/ Sequencing | 23939622 | |
| ZFNs | NHEJ | 16.70 | MDNA/SSA assay | 19470664 | ||
| TALENs | NHEJ | 20 | MDNA | 21179091 | ||
| HBB | CRISPR/Cas9 | NHEJ | 70 | T7E1 assay/ Sequencing | 23939622 | |
| ZFNs | NHEJ, HR | 2.1/12.9 | Sequencing | 21898685 | ||
| TALENs | NHEJ | NA | Reporter gene addition assay | 22301904 | ||
| Prkdc | CRISPR/Cas9 | NHEJ | 66.70 | T7E1 assay | 24598943 | |
| ZFNs | NHEJ | NA | Sequencing | 22981234 | ||
| TALENs | NA | NA | NA | NA | ||
| ben-1 | CRISPR/Cas9 | NHEJ | 88 | Sequencing | 24013562 | |
| ZFNs | NHEJ | 3.50 | MDNA & high-throughput sequencing | 21700836 | ||
| TALENs | NHEJ | 3.50 | MDNA | 21700836 | ||
| gria3a | CRISPR/Cas9 | NHEJ | 61 | T7E1 assay | 23360964 | |
| ZFNs | NHEJ | 26 | Sequencing | 21822241 | ||
| TALENs | NHEJ | 15 | Sequencing | 21822241 | ||
| TALENs | NA | NA | SSA assay | 21493687 | ||
| ADH1 | CRISPR/Cas9 | NHEJ | 8 | HRMA, sequencing | 24836556 | |
| ZFNs | NHEJ | 16 | Restriction-enzyme- resistance assay | 20508152 | ||
| TALENs | NHEJ, HR | NA | SSA assay, & restriction-enzyme- resistance assay | 21493687 | ||
| BLOS2 | CRISPR/Cas9 | NHEJ | 35.60 | PCR | 24165890 | |
| ZFNs | NHEJ | 0 | Reporter gene disruption assay/ direct sequencing | 20692340 | ||
| TALENs | NHEJ | 0.45 | Reporter gene disruption assay | 23028749 |
NHEJ, non homologous end joining; HR, homologous recombination; PCR, polymerase chain reaction; ZFNs, zinc finger nucleases; TALENs, transcription activator like effector nucleases; T7E1, T7 endonuclease1 assay; HRMA, high resolution melting assay; SSA, single strand annealing; MDNA, mismatch-detection nuclease assay.